Appointed
Theresa E. Wagler
Member of the Board
STLD ·
STEEL DYNAMICS INC
Effective immediately, the Board appointed Ms. Wagler as a member of the Board
Executive movement radar
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 451–500 of 76231
Role change
Christopher Graham
Executive Vice President and Chief Operating Officer Flat Rolled Steel Operations
STLD ·
STEEL DYNAMICS INC
Christopher Graham, the Company’s Senior Vice President Flot Roll Steel Group, will become the Company’s Executive Vice President and Chief Operating Officer Flat Rolled Steel Operations
Role change
Mark D. Millett
Executive Chairman
STLD ·
STEEL DYNAMICS INC
Mark D. Millett, Steel Dynamics, Inc.’s (the “Company”) Chairman and Chief Executive Officer gave notice to the Company’s Board of Directors (the “Board”) of his intention to retire as Chief Executive Officer of the Company effective January 1, 2027.
Role change
Barry Schneider
Executive Vice President and Chief Technology Officer
STLD ·
STEEL DYNAMICS INC
Barry Schneider, the Company’s President and Chief Operating Officer, will become the Company’s Executive Vice President and Chief Technology Officer
Appointed
Roman Franklin
Chief Financial Officer
VVOS ·
Vivos Therapeutics, Inc.
Effective July 31, 2026, the Board appointed Roman Franklin, age 42, as the Company’s Chief Financial Officer, and designated Mr. Franklin as the Company’s principal financial officer for purposes of the Securities Exchange Act of 1934, as amended.
Departed
Bradford Amman
Chief Financial Officer and Secretary
VVOS ·
Vivos Therapeutics, Inc.
On July 31, 2026, Bradford Amman resigned as Chief Financial Officer and Secretary of the Company, and from all other officer and committee positions held by reason of his employment, effective as of that date.
Appointed
Myriam J. Curet, M.D.
Class II director
MOBI ·
Mobia Medical, Inc.
Effective July 30, 2026, the Board of Directors (the “ Board ”) of Mobia Medical, Inc. (“ Mobia ”) increased the size of the Board from seven to eight members and appointed Myriam J. Curet, M.D. as a new member of the Board.
Departed
Julie Feder
Director
OBX ·
Gazelle Parent, Inc.
J. Mel Sorensen, M.D. and Julie Feder resigned from the Board and committees of the Board on which they respectively served, which resignations were not the result of any disagreements with our company relating to our operations, policies or practices.
Appointed
Madan Jagasia, M.D., M.S.
Director
OBX ·
Gazelle Parent, Inc.
the Board was reconstituted as follows: Peter Barrett, Ph.D., Matthew Norkunas, M.D., M.B.A., Heidi Hagen, Madan Jagasia, M.D., M.S., Maria Fardis, Ph.D., M.B.A., and Robert Ross, M.D. (each designated by Legacy Obsidian).
Appointed
Heidi Hagen
Director
OBX ·
Gazelle Parent, Inc.
the Board was reconstituted as follows: Peter Barrett, Ph.D., Matthew Norkunas, M.D., M.B.A., Heidi Hagen, Madan Jagasia, M.D., M.S., Maria Fardis, Ph.D., M.B.A., and Robert Ross, M.D. (each designated by Legacy Obsidian).
Departed
J. Mel Sorensen, M.D.
Director
OBX ·
Gazelle Parent, Inc.
J. Mel Sorensen, M.D. and Julie Feder resigned from the Board and committees of the Board on which they respectively served, which resignations were not the result of any disagreements with our company relating to our operations, policies or practices.
Appointed
Matthew Norkunas, M.D., M.B.A.
Director
OBX ·
Gazelle Parent, Inc.
the Board was reconstituted as follows: Peter Barrett, Ph.D., Matthew Norkunas, M.D., M.B.A., Heidi Hagen, Madan Jagasia, M.D., M.S., Maria Fardis, Ph.D., M.B.A., and Robert Ross, M.D. (each designated by Legacy Obsidian).
Appointed
Maria Fardis, Ph.D., M.B.A.
Director
OBX ·
Gazelle Parent, Inc.
the Board was reconstituted as follows: Peter Barrett, Ph.D., Matthew Norkunas, M.D., M.B.A., Heidi Hagen, Madan Jagasia, M.D., M.S., Maria Fardis, Ph.D., M.B.A., and Robert Ross, M.D. (each designated by Legacy Obsidian).
Appointed
Maria Fardis, Ph.D., M.B.A.
Chairperson of the Board
OBX ·
Gazelle Parent, Inc.
Maria Fardis, Ph.D. was appointed Chairperson of the Board.
Appointed
Peter Barrett, Ph.D.
Director
OBX ·
Gazelle Parent, Inc.
the Board was reconstituted as follows: Peter Barrett, Ph.D., Matthew Norkunas, M.D., M.B.A., Heidi Hagen, Madan Jagasia, M.D., M.S., Maria Fardis, Ph.D., M.B.A., and Robert Ross, M.D. (each designated by Legacy Obsidian).
Appointed
Robert Ross, M.D.
Director
OBX ·
Gazelle Parent, Inc.
the Board was reconstituted as follows: Peter Barrett, Ph.D., Matthew Norkunas, M.D., M.B.A., Heidi Hagen, Madan Jagasia, M.D., M.S., Maria Fardis, Ph.D., M.B.A., and Robert Ross, M.D. (each designated by Legacy Obsidian).
Appointed
Angel Yik
Director and Secretary, as Chief Financial Officer (CFO)
Nano Mobile Healthcare, Inc.
Angel Yik as Director and Secretary, as Chief Financial Officer (CFO)
Appointed
Cheng Chung Yu
Director and Chief Executive Officer
Nano Mobile Healthcare, Inc.
Cheng Chung Yu (Neptune (HK)) as Director and Chief Executive Officer CEO
Appointed
Cheng Chung Sing
Director, Chairman of the Board
Nano Mobile Healthcare, Inc.
Cheng Chung Sing (Byron) as Director, Chairman of the Board
Appointed
James Ahlers
Chief Financial Officer
CUE ·
Cue Biopharma, Inc.
On August 3, 2026, Cue Biopharma, Inc. (the “Company”) announced that the Company’s Board of Directors (the “Board”) appointed James Ahlers as the Company’s Chief Financial Officer, effective as of July 30, 2026 (the “Effective Date”).
Appointed
Julie Sawyer Montgomery
Director
DHR ·
DANAHER CORP /DE/
The Board also appointed Ms. Sawyer Montgomery to the Board and to each of the Executive, Finance and Science & Technology Committees of the Board, in each case effective as of the Effective Date.
Appointed
Julie Sawyer Montgomery
President and Chief Executive Officer
DHR ·
DANAHER CORP /DE/
the Board of Directors of the Company (the “Board”) has appointed Julie Sawyer Montgomery as President and Chief Executive Officer of the Company (the “CEO”).
Appointed
Matthew Casaccia
Board of Managers
DBC ·
Invesco DB Commodity Index Tracking Fund
appointed Mr. Matthew Casaccia to serve on the Board of Managers of the Managing Owner, effective as of the close of business on August 3, 2026
Departed
Jordan Krugman
Board of Managers
DBC ·
Invesco DB Commodity Index Tracking Fund
Mr. Casaccia will replace Mr. Jordan Krugman, who, as previously disclosed, gave notice of his resignation from the Board of Managers of the Managing Owner as of the Effective Date.
Departed
Jordan Krugman
Board of Managers
BTCO ·
Invesco Galaxy Bitcoin ETF
Mr. Casaccia will replace Mr. Jordan Krugman, who, as previously disclosed, gave notice of his resignation from the Board of Managers of the Sponsor as of the Effective Date.
Appointed
Matthew Casaccia
Board of Managers
BTCO ·
Invesco Galaxy Bitcoin ETF
appointed Mr. Matthew Casaccia to serve on the Board of Managers of the Sponsor, effective as of the close of business on August 3, 2026
Appointed
Blair C. Jackson
Director
ALKS ·
Alkermes plc.
the Board approved an increase to the size of the Board from nine to ten directors and appointed Mr. Jackson as a member of the Board for a term expiring at the Company’s 2027 annual general meeting of shareholders and as a member of the Financial Operating Committee of the Board, in each case effective August 1, 2026.
Role change
Blair C. Jackson
President and CEO
ALKS ·
Alkermes plc.
On July 28, 2026, the Board took action to expand Mr. Jackson’s responsibilities and, commensurate with such expansion, to also appoint Mr. Jackson as President of the Company, effective August 1, 2026, and to approve Mr. Jackson’s compensation arrangements for his role as President and CEO, in each case effective August 1, 2026.
Appointed
Cory S. Gunderson
President and Chief Executive Officer - Protiviti
RHI ·
ROBERT HALF INC.
the Company announced that effective January 1, 2027 (“the Effective Date”), Cory S. Gunderson will succeed Mr. Tarantino and serve as President and Chief Executive Officer - Protiviti.
Role change
Joseph A. Tarantino
President and Chief Executive Officer – Protiviti
RHI ·
ROBERT HALF INC.
Joseph A. Tarantino has informed the Board of Directors that effective December 31, 2026 he will transition from his position as President and Chief Executive Officer – Protiviti to a new position as Senior Managing Director, Protiviti commencing January 1, 2027.
Appointed
Rhonda Davenport
Chief Human Resources Officer
AZZ ·
AZZ INC
Effective August 3, 2026, the Board of Directors (the “ Board ”) of AZZ Inc. (the “ Company ”) appointed Ms. Rhonda Davenport, 43, as Chief Human Resources Officer.
Appointed
Stephen Ken Adair
President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary, and Director
IVHI ·
Invech Holdings, Inc.
Simultaneously, the following individual was elected: Stephen Ken Adair as its President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary, and Director.
Departed
Alexander M. Woods-Leo
President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary, and Director
IVHI ·
Invech Holdings, Inc.
Effective August 3, 2026, the Company accepted the resignation of Alexander M. Woods-Leo from all of his positions with the Company, including President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary, and Director.
Appointed
Michael Grissinger
director
LPCN ·
Lipocine Inc.
On August 3, 2026, the Board of Directors of the Company expanded the Board of Directors to five members and appointed Michael Grissinger as a director, effective immediately.
Appointed
Amiee Lynn Thomas
Director
CAVA ·
CAVA GROUP, INC.
On July 29, 2026, the Board of Directors (the “Board”) of CAVA Group, Inc. (the “Company”) appointed Amiee Lynn Thomas to the Board.
Appointed
(interim)
Joel Krutz
interim Chief Executive Officer
AMZE ·
AMAZE HOLDINGS, INC.
On July 31, 2026, the Board appointed Joel Krutz, the Company’s Chief Financial Officer, to serve as interim Chief Executive Officer of the Company, effective immediately, while the Board conducts a search for a permanent successor.
Departed
(interim)
Aaron Day
Chief Executive Officer
AMZE ·
AMAZE HOLDINGS, INC.
On July 31, 2026, the Board of Directors (the “Board”) of Amaze Holdings, Inc. (the “Company”) determined that Aaron Day would no longer serve as Chief Executive Officer of the Company, effective immediately.
Role change
Michael Pruitt
Chairman of the Board
AMZE ·
AMAZE HOLDINGS, INC.
On July 31, 2026, the Board appointed Michael Pruitt, previously Vice Chairman of the Board, to serve as Chairman of the Board, effective immediately.
Appointed
Bernd Leukert
Class II Director
TDC ·
TERADATA CORP /DE/
Bernd Leukert is elected as a Class II director with a term expiring at the 2027 Annual Meeting
Appointed
Carl Carande
Director
UCB ·
UNITED COMMUNITY BANKS INC
Effective August 1, 2026, the Board of Directors (the “Board”) of United Community Banks, Inc. (the “Company”) appointed Carl Carande to serve as a Board member until the Company’s next annual meeting of shareholders.
Departed
Sefton Cohen
Chief Revenue Officer
RSSS ·
Research Solutions, Inc.
On July 31, 2026, Research Solutions, Inc. terminated Sefton Cohen from the position of Chief Revenue Officer.
Appointed
David Kutil
Chief Financial Officer
RSSS ·
Research Solutions, Inc.
On July 28, 2026, Research Solutions, Inc. (the “Company”) appointed Dave Kutil as the Company’s Chief Financial Officer (“CFO”).
Departed
Wm. Gordon Prescott
General Counsel and Corporate Secretary
BBT ·
Beacon Financial Corp
the retirement of Wm. Gordon Prescott as General Counsel and Corporate Secretary effective as of July 31, 2026.
Appointed
John B. Eagan
General Counsel and Corporate Secretary
BBT ·
Beacon Financial Corp
the appointment of John B. Eagan as General Counsel and Corporate Secretary effective as of August 1, 2026.
Appointed
Jonathan M. Dale
President
AVBH ·
Avidbank Holdings, Inc.
On August 3, 2026, Avidbank Holdings, Inc. (the “Company”), and Avidbank, a California state-chartered bank and a wholly owned subsidiary of the Company (the “Bank”) announced that it has appointed Jonathan M. Dale as President of the Company and the Bank.
Role change
Mark D. Mordell
President
AVBH ·
Avidbank Holdings, Inc.
On the Effective Date and in connection with the appointment of Mr. Dale, Mark D. Mordell, the Company’s and the Bank’s current Chairman, President and Chief Executive Officer, will continue to serve in the role of Chairman and Chief Executive Officer of the Company and the Bank, and no longer serve as President.
Departed
Brendan Hannah
Chief Operating Officer, Chief Business Officer and Chief Compliance Officer
QNCX ·
Quince Therapeutics, Inc.
each of Dirk Thye, the Chief Executive Officer and Chief Medical Officer of Quince Therapeutics, Inc. (the “ Company ”), and a member of the Company’s board of directors (the “ Board ”), and Brendan Hannah, the Company’s Chief Operating Officer, Chief Business Officer and Chief Compliance Officer, tendered conditional resignations from their positions with the Company
Appointed
John Militello
Chief Financial Officer
QNCX ·
Quince Therapeutics, Inc.
John Militello, CPA , age 52, was conditionally appointed as the Company’s Chief Financial Officer
Appointed
Brigette Roberts
Chief Executive Officer
QNCX ·
Quince Therapeutics, Inc.
Brigette Roberts, M.D. , age 50, was conditionally appointed as the Company’s Chief Executive Officer
Departed
Dirk Thye
Chief Executive Officer and Chief Medical Officer
QNCX ·
Quince Therapeutics, Inc.
each of Dirk Thye, the Chief Executive Officer and Chief Medical Officer of Quince Therapeutics, Inc. (the “ Company ”), and a member of the Company’s board of directors (the “ Board ”), and Brendan Hannah, the Company’s Chief Operating Officer, Chief Business Officer and Chief Compliance Officer, tendered conditional resignations from their positions with the Company
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.